随着组织工程学技术的进展,利用培养的自身组织细胞种植于支架材料表面,体外重新构建理想的心脏瓣膜移植物日益成为瓣膜外科的研究热点。
With the development of tissue engineering technology. Tissue engineering of heart valve by seeding cells and scaffolds has become a hot issue in valve surgery.
所述组合物和方法用于治疗自身免疫、炎症、过敏、哮喘、移植排斥、移植物抗宿主疾病、感染、脓毒、癌症和免疫缺陷。
The compositions and methods have use in the treatment of autoimmunity, inflammation allergy, asthma, graft rejection, graft versus host disease, infection, sepsis, cancer and immunodeficiency.
应用推荐